Opendata, web and dolomites

PLASREVOLUTION SIGNED

Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLASREVOLUTION project word cloud

Explore the words cloud of the PLASREVOLUTION project. It provides you a very rough idea of what is the project "PLASREVOLUTION" about.

compensation    medicine    pivotal    scenarios    superbugs    alleviated    bacterial    clones    transfer    despite    surgery    molecular    modern    breaking    patients    conjugation    society    microbiome    evolution    central    treatments    plasmids    host    resistance    time    uncontrollably    mainly    patient    completely    post    entail    fuelled    meeting    hospitalized    settings    bridge    extensive    life    compensatory    obj    dynamic    genetic    antibiotics    inappropriate    dawn    successful    pathogenic    transmission    ar    cancer    infectious    opening    spread    bacteria    plan    diseases    clinical    clone    gap    plasmid    horizontal    treatment    contexts    gut    mechanisms    fitness    first    basis    drive    indispensable    bacterium    subsequently    tools    exploring    mediated    play    associations    clinically    antibiotic    underlying    arrive    unprecedentedly    coevolution    chemotherapy    avenues    unexplored    resolution    dynamics    genes    era    interventions    constricted    ground   

Project "PLASREVOLUTION" data sheet

The following table provides information about the project.

Coordinator
SERVICIO MADRILENO DE SALUD 

Organization address
address: PLAZA CARLOS TRIAS BERTRAN 7
city: MADRID
postcode: 28020
website: http://cort.as/10Yf

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙497˙314 €
 EC max contribution 1˙497˙314 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERVICIO MADRILENO DE SALUD ES (MADRID) coordinator 1˙497˙314.00

Map

 Project objective

Antibiotics are essential tools in modern medicine and are indispensable not only for the treatment of infectious diseases but also to support other key interventions such as surgery and cancer chemotherapy. However, the extensive and inappropriate use of antibiotics has fuelled the spread of resistance mechanisms in pathogenic bacteria, leading to the dawn of a post-antibiotic era. Plasmids play a pivotal role in the evolution of antibiotic resistance (AR) because they drive the horizontal transfer of resistance genes between pathogenic bacteria by conjugation. Some of these plasmid-bacterium associations become particularly successful, creating superbugs that spread uncontrollably in clinical settings. The rise of these clones is mainly constricted because plasmids entail a fitness cost when they arrive in a new bacterial host. This cost can be subsequently alleviated through compensatory adaptation during plasmid-bacterium coevolution. Despite the importance of this cost-compensation dynamic in the evolution of plasmid-mediated AR, it remains completely unexplored in clinical contexts. In this project I plan to bridge this gap by exploring the genetic basis underlying the evolution of plasmid-mediated AR in clinically relevant scenarios. We will study, for the first time, the intra-patient transmission, fitness cost and adaptation of AR plasmids in the gut microbiome of hospitalized patients (obj. 1). We will analyse the molecular mechanisms that determine the success of AR plasmids and bacterial clone associations (obj. 2). Finally, we will develop new technology to test how antibiotic treatments affect AR plasmids dynamics in the gut microbiome at an unprecedentedly high-resolution (obj. 3). This ground-breaking project will allow a new understanding of the evolution of plasmid-mediated AR in real life, opening new research avenues and providing a major step towards meeting one of the central challenges facing our society: controlling the spread of AR.

 Publications

year authors and title journal last update
List of publications.
2019 R. Craig MacLean, Alvaro San Millan
The evolution of antibiotic resistance
published pages: 1082-1083, ISSN: 0036-8075, DOI: 10.1126/science.aax3879
Science 365/6458 2019-10-03
2018 Alvaro San Millan
Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context
published pages: , ISSN: 0966-842X, DOI: 10.1016/j.tim.2018.06.007
Trends in Microbiology monthly 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLASREVOLUTION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLASREVOLUTION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

EXTREME (2020)

The Epistemology and Ethics of Fundamentalism

Read More  

THERMONANO (2018)

Nanoassemblies for the subcutaneous self-administration of anticancer drugs

Read More  

CURVE-X (2019)

Industrialisation of curved sensors and related imagers

Read More